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ABSTRACT 
Whether the specific blood transfer conductance for nitric oxide (NO) with hemoglobin (șNO) is 
finite or infinite is controversial but important in the calculation of alveolar capillary membrane 
conductance (DmCO) and pulmonary capillary blood volume (VC) from values of lung diffusing 
capacity for carbon monoxide (DLCO) and nitric oxide (DLNO). In this review, we discuss the 
background associated with șNO, explore the resulting values of DmCO and VC when applying 
either assumption, and investigate the mathematical underpinnings of DmCO and VC calculations. 
In general, both assumptions yield reasonable rest and exercise DmCO and VC values. However, 
the finite șNO assumption demonstrates increasing VC, but not DmCO, with submaximal exercise. 
At relatively high, but physiologic, DLNO/DLCO ratios both assumptions can result in 
asymptotic behavior for VC values, and under the finite șNO assumption, DmCO values. In 
conclusion, we feel that the assumptions associated with a finite șNO require further in vivo 
validation against an established method before widespread research and clinical use. 
 
Keywords 
Lung diffusing capacity, alveolar capillary membrane conductance, pulmonary capillary blood 
volume, exercise, in vivo validation 
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1. INTRODUCTION 
There remains significant uncertainty as to the correct specific blood transfer conductance for 
nitric oxide (NO) with hemoglobin (șNO) when studying lung diffusing capacity even in light of 
the ERS task force findings (Zavorsky et al., 2017). Specifically, there is currently a debate as to 
whether to assume an infinite or finite șNO when calculating alveolar-capillary membrane 
conductance (DmCO) and pulmonary-capillary blood volume (VC) from measures of lung 
diffusing capacity for CO (DLCO) and NO (DLNO). While our laboratory has consistently held 
the original assumption that șNO is effectively infinite, other groups have begun applying a finite 
value for șNO of 4.5 mlCO/min/mmHg/mlblood measured via an in vitro study and supported by 
animal and human studies not designed to calculate an exact șNO value (Borland and Cox, 1991; 
Borland et al., 2010; Guenard et al., 2016; Zavorsky et al., 2014). Based on this limited work, a 
task force has recently recommended the use of a finite șNO; however, we believe these 
recommendations, including those concerning șNO and also the correct DmNO/DmCO ratio, are 
premature (Zavorsky et al., 2017). In this manuscript, we will begin by summarizing the 
evolution of, and the scientific reasoning behind, the original assumption that șNO is effectively 
infinite. Next, using both published and preliminary data from our laboratory, we will show in 
GHWDLOWKHHIIHFWRIDVVXPLQJDQLQILQLWHșNO vs. using a finite value of 4.5 
mlCO/min/mmHg/mlblood on calculation of DmCO and VC values in vivo in humans. We will do 
this for lung diffusing capacity data collected using different techniques (i.e. rebreathe and 
single-breath) and in different populations (i.e. healthy and heart failure, young and old age) at 
rest and during exercise. Furthermore, we will extend these findings to an investigation of the 
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mathematical limits within which each assumption yields reasonable, physiologic values for 
DmCO and VC; i.e., positive values on the same order of magnitude as values previously reported 
in the literature. Finally, we will discuss the implications of our findings and offer insight into 
future research, as well as clinical practice, UHJDUGLQJWKHXVHRIDQLQILQLWHYHUVXVDILQLWHșNO in 
the calculation of DmCO and Vc in vivo in humans. As we will show, both assumptions yield 
reasonable values for DmCO and VC at rest. However, the assumption that șNO is finite can yield 
values which do not increase with submaximal exercise; this is clearly a concern, as DmCO and 
VC would be anticipated to increase during the exercise levels included in these data. 
Additionally, using a finite șNO requires more assumptions GXULQJFDOFXODWLRQVĮKrogh 
FRHIILFLHQWșCO equation, șNO) than applying an infinite șNO Į.URJKFRHIILFLHQWșCO equation). 
As such, while the use of a finite șNO value may have merit, we urge caution in its application for 
the calculation of DmCO and Vc in humans until the method can be properly validated against the 
multiple O2 tension method. Overall, we feel that it is more important to interpret DmCO and VC 
as physiologic variables rather than anatomical measurements and to interpret changes over time 
or between groups rather than to focus on the specific method used. 
 
1.1 Theory and evidence for an infinite vs. finite șNO 
In our laboratory, we use two methods for the determination of DLCO: 1) a single breath 
technique, and 2) a rebreathe technique. The single breath technique for measuring DLCO was 
first described in 1909 (Krogh and Krogh, 1910; Krogh, 1915), but the methodology currently in 
common use was established in 1954 (Forster et al., 1954). This technique requires the 
participant to take a deep inspiration from residual volume to total lung capacity of a test gas 
containing approximately 10% helium, 0.3% CO, 21% oxygen, and balance nitrogen, followed 
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by a short breath hold (typically 4 to 10 seconds), with a subsequent swift expiration. Simply put, 
the ratio of inspired to expired CO concentrations, after taking into account dead space and 
alveolar mixing, yields the diffusing capacity of the lungs for CO (DLCO). The rebreathe 
technique used in our laboratory to measure DLCO requires participants to rebreathe from a bag 
containing 9% Helium, 0.3% C18O, 35% O2, and balance nitrogen for 8 to 10 tidal breaths 
(Ceridon et al., 2010; Meyer et al., 1990; Sackner et al., 1975). The assumptions of the rebreathe 
technique are identical to that of the single breath method. However, the rebreathe technique 
often yields lower values for DmCO and VC; while this inconsistency is not completely 
understood, it is not the focus of the manuscript and hence, we will separate results for both 
techniques for clarity. 
 
In 1957, Roughton and Forster extended this technique and established a method for determining 
DmCO and VC by measuring DLCO at multiple O2 concentrations (Roughton and Forster, 1957). 
In short, because CO and hemoglobin competitively bind hemoglobin, a higher partial pressure 
of oxygen (PO2) in the pulmonary capillaries yields a lower DLCO. Taking advantage of this, it 
is then possible to separate the contribution of resistances to gas transfer due to both the alveolar 
capillary membrane (Dm) and the pulmonary capillary blood volume (Vc) by graphing 1/DLCO 
DJDLQVWșCO and fitting the resulting points. Specifically, DmCO will be equal to the inverse of 
the y-intercept and VC will be equal to the inverse of the slope of the regression line, according 
to the following equation developed by Roughton and Forster (Roughton and Forster, 1957): 
  ?ܦܮܥܱ ൌ  ?ܦ݉஼ை ൅  ?ߠ஼ை כ ஼ܸ 
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However, this method is less than ideal, as it is not only time-consuming, but also requires the 
assumption that measurements of DLCO separated by multiple minutes represent an identical 
physiologic state unaffected by varying oxygen tensions, i.e. the same CO distribution 
throughout the lung during breath hold and the same cardiac output during the maneuver. 
Despite these shortcomings, this multiple-O2 tension method is considered the µgold standard¶ 
for the calculation of DmCO and VC. 
 
,QWKHODWH¶VDPHWKRGZDVGHYHORSHGin which DLNO is measured simultaneously with 
DLCO by the addition of 40 ppm NO to the gas mixture and has quickly become the technique 
of choice as it removes the issues described above associated with the multiple O2 tension 
method (Borland and Higenbottam, 1989; Guenard et al., 1987). The theory behind this method is 
that the rate of reaction of NO with hemoglobin in vitro is extremely rapid, approximately two orders of 
magnitude greater than șCO  (Borland and Higenbottam, 1989; Hakim et al., 1996).. Furthermore it is 
assumed that the extremely rapid reaction of NO with hemoglobin extends to the intact red cell in vivo. In 
this way, the resistance to NO transfer from the alveoli onto hemoglobin can be assumed to be 
only dependent on alveolar capillary membrane resistance and independent of the volume of 
pulmonary capillary blood present. This technique simplifies calculation of DmCO and VC, as it 
does not require tests to be performed at several oxygen tensions, therefore removing the 
necessity of assuming that the physiologic state is the same across multiple trials and also 
shortening the time required to obtain data (detailed calculations are described in sections 2.1-2 
³$VVXPSWLRQVDQG&DOFXODWLRQV´. 
 
More recently, however, it has been argued that the assumption that șNO is infinite is not valid. 
Indeed, it has been demonstrated by multiple groups that the specific blood transfer conductance 
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for NO with free hemoglobin is anywhere from 100 to over 1000 times faster than that with red 
blood cells, suggesting that the red blood cell does in fact have a meaningful resistance to the 
diffusion of NO. These studies have been completed in several animal species and using various 
methods (Azarov et al., 2011; Borland et al., 2006; Borland et al., 2010; Carlsen and Comroe, 
1958; Deonikar and Kavdia, 2010; Liu et al., 1998; Vaughn et al., 2000). Accordingly, it has 
been argued by some researchers that șNO cannot, by definition, be infinite as a red cell resistance 
does in fact exist. Indeed, several in vitro studies find evidence for a finite specific blood transfer 
conductance for NO (Azarov et al., 2011; Sakai et al., 2008); however, these studies do not 
provide evidence as to the appropriate value for in vivo experiments. Furthermore, the in vivo 
value recently recommended for șNO by the ERS task force  is based on only three papers. Each 
of these papers has limitations; either the studies were performed in vitro or in animals, or the 
study has a large degree of variability in the value obtained (for further discussion, see section 
3.3 ³Required assumptions/problems of each method´) (Borland et al., 2010; Carlsen and 
Comroe, 1958; Guenard et al., 2016). Importantly, we recognize that it is likely impossible to 
directly PHDVXUHșNO in vivo in humans, and as such these studies are meaningful first steps in 
determining the value of șNO (currently suggested to be 4.5 mlCO/min/mmHg/mlblood). However, 
ZHIHHOWKDWWKLVșNO value needs to be validated and/or optimized with respect to a method that 
does not utilize NO as a means to gain confidence in its application\. 
 
So, the question becomes: should șNO be considered infinite or finite in the calculation of DmCO 
and VC? In order to investigate the outcomes of both methods, we have calculated DmCO and VC 
while applying both a finite and infinite șNO for over 750 DLCO and DLNO measurements from 
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our laboratory. What follows includes an overview of these calculations, details on the dataset 
used, and the outcomes of this analysis. 
 
2. METHODS 
2.1 Assumptions and Calculations - Infinite șNO 
As we and others have demonstrated previously, the calculation of DmCO and VC when assuming 
that șNO is infinite is critically dependent on two key considerations.  First, it is essential that the 
correct equation for calculating șCO is chosen. Second, the ratio of DmNO to DmCO (termed Į) 
must be established. While there exists a theoretical value for Į that is based on the molecular 
weights and solubilities in water of both NO and CO (termed the Krogh coefficient), numerous 
studies utilizing an infinite șNO have experimentally determined that Į is actually greater than 
1.97 (Magini et al., 2013; Tamhane et al., 2001). Accordingly, we have previously 
experimentally determined the best șCO equation and Į value to be used, for both the rebreathe 
and single breath techniques (Ceridon et al., 2010; Coffman et al., 2016), by systematically 
comparing the resulting DmCO and VC values against those obtained via the original multiple O2 
tension method. From both of these studies, our laboratory has concluded that the șCO equation 
described by Reeves and Park is ideal, while the optimal Į value is dependent on the technique 
used; ~2.26 for rebreathe and ~4.40 for single breath. This difference can be understood by 
recognizing that the single breath method, in our laboratory and others, often yields DLNO 
values somewhat higher than the rebreathe method (Ceridon et al., 2010; Ceridon et al., 2011; 
Coffman et al., 2016; Snyder et al., 2007; Zavorsky et al., 2014; Zavorsky and Murias, 2006; 
Zavorsky et al., 2004). Of note, while this inconsistency in DLNO values between the two 
methods in not completely understood, it is not the focus of this manuscript. Importantly, the 
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chosen Į value for each method ensures that calculated DmCO values are in agreement with those 
obtained via the original multiple O2 tension method, which does NOT rely on measures of 
DLNO. Details of the calculation of DmCO and VC, under the assumption that șNO is effectively 
infinite, are as follows: 
  ?ܦܮܱܰ ൌ  ?ܦ݉ேை ൅  ?ߠேை כ ஼ܸ ߠேை ൎ  ?   ?ܦܮܱܰ ൌ  ?ܦ݉ேை ൅  ? ?  ܦܮܱܰ ൌ  ܦ݉ேை ܦ݉஼ை ൌ  ܦ݉ேைߙ ൌ ܦܮܱܰߙ  ݓ݄݁ݎ݁ߙ ൌ  ?Ǥ ? ?ሺݎܾ݁ݎ݁ܽݐ݄݁ሻ݋ݎߙ ൌ  ?Ǥ ? ?ሺݏ݈݅݊݃݁ܾݎ݁ܽݐ݄ሻ  ?ܦܮܥܱ ൌ  ?ܦ݉஼ை ൅  ?ߠ஼ை כ ஼ܸ ݏ݋ݐ݄ܽݐ ஼ܸ ൌ  ?ߠ஼ை כ ൬  ?ܦܮܥܱ െ  ?ܦ݉஼ை൰ିଵ ݓ݄݁ݎ݁ ଵఏ಴ೀ ൌ  ?Ǥ ? ? ?כ ܱܲଶ ൅  ?Ǥ ? ? ? ? (Reeves and Park, 1992) 
 
2.2 Assumptions and Calculations - Finite șNO 
When calculating DmCO and VC using a finite șNO, three assumptions must be established. First, 
the correct șCO equation must be determined; Zavorksy et al. have chosen to use the equation 
reported by Guenard in 2016 (Forster, 1987; Guenard et al., 2016). Second, the Į ratio must be 
determined; most groups that assume a finite șNO have chosen to use an approximation of the 
Krogh coefficient, equal to 2. This Krogh coefficient, DQGWKHĮUDWLRXVHGXQGHUWKHLQILQLWHșNO 
assumption, are similar, as they both convert DmNO to DmCO. The relationship of Į and the 
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Krogh coefficient and why Į differs between the methods is discussed later (see Fig. 4, as well as 
section 3.3 ³5HTXLUHGDVVXPSWLRQVSUREOHPVRIHDFKPHWKRG´). Third, the value for șNO must be 
chosen; șNO is currently set to a value of 4.5 mlCO/min/mmHg/mlblood (see section 3.3 ³Required 
assumptions/problems of each method´ for more details)
 
(Carlsen and Comroe 1958). Details of 
the calculation of DmCO and VC, under the assumption that șNO is finite, are as follows: 
  ?ܦܮܥܱ ൌ  ?ܦ݉஼ை ൅  ?ߠ஼ை כ ஼ܸ  ?ܦܮܱܰ ൌ  ?ܦ݉ேை ൅  ?ߠேை כ ஼ܸ ܭݎ݋݄݃ܿ݋݂݂݁݅ܿ݅݁݊ݐ ൌ  ?ݏݑ݄ܿݐ݄ܽ ݐܦ݉஼ை ൌ  ܦ݉ேை ?  ݎ݁ܽݎݎܽ݊݃݅݊݃Ǣ ܦ݉ேை ൌ ߠேை െ  ? כ ߠ஼ைߠேைܦܮܱܰ െ ߠ஼ைܦܮܥܱ ݓ݄݁ݎ݁ߠேை ൌ  ?Ǥ ? ܦ݉஼ை ൌ  ܦ݉ேை ?  
஼ܸ ൌ  ?ߠ஼ை כ ൬  ?ܦܮܥܱ െ  ?ܦ݉஼ை൰ିଵ ݓ݄݁ݎ݁ ଵఏ಴ೀ ൌ  ?Ǥ ? ? ? ?כ ܱܲଶ ൅  ?Ǥ ? ? (Guenard et al., 2016) 
 
3. RESULTS 
3.1 Effect of infinite vs. finite șNO assumption on actual data 
In order to determine the effect of a finite vs. infinite șNO on calculated values of DmCO and VC, 
the data discussed next includes over 750 observations (an observation is a single, simultaneous 
measurement of DLCO and DLNO on a study participant) from our laboratory using both the 
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rebreathe and single breath methods, from which we have calculated DmCO and VC using both 
the infinite and finite șNO assumptions described above (see sections 2.1-2 ³$VVXPSWLRQVDQG
&DOFXODWLRQV´). Table 1 details the source of these data points; this includes data from healthy 
and heart failure participants, younger and older individuals, and rest as well as submaximal or 
incremental exercise trials. Therefore, these data span multiple variations in potential values of 
DLCO and DLNO, as well as DmCO and VC (Table 2). 
 
Figure 1 and Figure 2, as well as Table 2, show the median and distribution for DmCO and VC 
values calculated assuming an infinite șNO DQGDILQLWHșNO using a rebreathe (Table 2, Figure 1) 
or single breath (Table 2, Figure 2) technique. Using the rebreathe method (Figure 1), both the 
infinite and finite șNO assumptions yield DmCO and VC values that qualitatively appear to be 
grouped in a physiological range and incorporate very few outliers. However, the DmCO values 
are statistically higher using the finite vs. infinite assumption. Quantitatively, the means, 
standard deviations, and number of outliers (defined as ± 2.7 standard deviations from the mean), 
are as follows: for DmCO: Infinite DmCO, 41.2 ± 17.7 ml/min/mmHg, 4 outliers; Finite DmCO, 
63.8 ± 31.1 ml/min/mmHg, 12 outliers (Infinite vs. Finite, p < 0.001); for VC: Infinite VC, 85.8 ± 
46.3 ml, 14 outliers; Finite VC, 89.8 ± 43.3 ml, 6 outliers (Infinite vs. Finite, p = 0.111). Using 
the single breath method (Figure 2), the findings are similar; DmCO and VC under both an infinite 
and finite șNO assumption are grouped in a physiologic range with few outliers. However, the 
mean DmCO values are statistically higher, and the VC values are statistically lower, using the 
finite vs. infinite assumption. The means, standard deviations, and number of outliers for the 
single breath method are as follows: for DmCO: Infinite DmCO, 49.5 ± 8.4 ml/min/mmHg, 3 
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outliers; Finite DmCO, 281.7 ± 81.5 ml/min/mmHg, 3 outliers (p < 0.001); for VC: Infinite VC, 
223.2 ± 141.2 ml, 5 outliers; Finite VC, 82.5 ± 18.7 ml, 2 outliers (p < 0.001). 
 
Such a difference in results between the finite and infinite assumption may complicate the ability 
to implement measures of DmCO and VC clinically. This is in contrast to the research 
environment, where we feel that the absolute values are of less importance, whereas the ability to 
observe changes between research groups or after an intervention is of the utmost importance. 
However, in order to implement DmCO and VC clinically, a single method to be implemented 
across the entire practice would simply need to be chosen. We discuss this idea further later (see 
section 4.3 ³Conclusions´ 
 
3.2 Exercise responses 
In healthy humans, exercise is associated with an increase in cardiac output and pulmonary 
perfusion pressure that causes both recruitment of under-perfused pulmonary capillaries and 
distension of already perfused pulmonary blood vessels, as evidenced by an increase in DLCO, 
DmCO, and VC (La Gerche et al., 2010; Tamhane et al., 2001; Taylor et al., 2014).  Therefore, it is 
crucial that measures of DmCO and Vc increase accordingly in response to exercise, regardless of 
ZKHWKHUșNO is assumed to be infinite or finite. 
  
We have simultaneously assessed DLCO and DLNO using the single-breath technique at rest 
and during submaximal exercise in two separate studies in our laboratory (Coffman et al., 2016). 
In the first study, DLCO and DLNO were measured in duplicate at rest and during cycle exercise 
at 80W in 11 healthy subjects (Table 1, #5). In the second study, DLCO and DLNO were again 
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measured in duplicate at rest and during cycle exercise at an intensity designed to elicit a 
doubling of resting cardiac output and at least ~70% of age predicted heart-rate maximum. This 
study was performed in 8 healthy subjects (Table 1, #6).  For the present analyses, the data from 
both studies were pooled, yielding a mean submaximal workload of 80 W, range 40 ± 130 W. 
 
In order to determine if DmCO and VC significantly increased with submaximal exercise, we 
performed a student's paired t-test on the data calculated under both infinite and finite șNO 
assumptions. Table 3 shows that, when assuming an infinite șNO, DmCO and VC increased 
significantly with submaximal exercise, as would be expected (DmCO at rest 45.6 ± 6.5 vs. 
exercise 53.7 ± 8.2 ml/min/mmHg, P < 0.001; VC at rest 162.6 ± 68.6 vs. exercise 288.9 ± 168.9 
ml, P < 0.001). On the other hand, only VC significantly increased under the finite șNO 
assumption, whereas DmCO was statistically unchanged (DmCO at rest 279.1 ± 95.4 vs. exercise 
284.5 ± 64.2 ml/min/mmHg, P = 0.498; VC at rest 72.7 ± 12.9 vs exercise 93.1 ± 18.3 ml, P < 
0.001). This is clearly concerning, as DmCO is expected to rise in concert with Vc with increasing 
exercise intensity. Thus, the lack of response suggests a likely flaw with the determination of 
these values when assuming a ILQLWHșNO (Lewis et al., 1958; Tamhane et al., 2001). 
 
We have also simultaneously assessed DLCO and DLNO using the rebreathe technique at rest 
and during incremental exercise in two separate studies in our laboratory. In the first study, 
DLCO and DLNO were measured at rest and during cycle exercise at 0, 10, 15, 30, 50, and 70% 
of Wpeak (determined during a maximal exercise test at a prior study visit). This study was 
performed in 7 healthy subjects (Table 1, #3). In the second study, DLCO and DLNO were 
measured in duplicate at rest and during cycle exercise at 25, 50, 75, and 90% of Wpeak 
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(determined during a maximal exercise test at a prior study visit). This study was performed in 
31 healthy subjects (Table 1, #4). For the present analysis, the data from both studies were 
pooled, and DmCO or VC was then plotted as a function of workload. Because these data 
incorporate repeat measures, a linear mixed effects model was used to separate the individual 
and group effects on either DmCO or VC with exercise. The group effect was then plotted for both 
variables under the infinite and finite assumptions (Figure 3). Whether an infinite or a finite șNO 
is assumed, DmCO and VC significantly increased with increasing workload (all P < 0.001). All in 
all, this suggests that assuming both an infinite or finite șNO yields statistically significant 
increases in DmCO and VC with incremental exercise when using the rebreathe method, as would 
be anticipated. 
 
3.3 Required assumptions/problems of each method 
Both the finite and infinite methods for calculating VC and DmCO from DLCO and DLNO rely 
on several values that likely impossible to measure directly in vivo in humans. The infinite 
method has two assumptions that must be optimized, the șCO coefficients and Į, while the finite 
method has the additional term, șNO. Because these values cannot be directly measured, our 
laboratory has taken the approach of systematically verifying these terms using the gold-standard 
multiple O2 tension method, which does not rely on measures of DLNO. By contrast, this 
rigorous optimization does not appear to have been done for the finite method.  
 
Both methods are very sensitive to the values chosen for the ĮUDWLR/Krogh FRHIILFLHQWșNO, and 
șCO coefficients:KLOHWKHGHWHUPLQDWLRQRIWKHRSWLPDOșCO coefficients is essential to the use of 
either method, the following section will IRFXVRQWKHĮUDWLR/Krogh coefficient. :KHQșNO and 
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șCO are required in the theoretical discussion going forward, we will use the values that have 
either been determined as optimal by our group for the infinite assumption, or the values 
currently used in the literature for the finite assumption. 
 
7KH.URJKFRHIILFLHQWXVHGZLWKWKHILQLWHDVVXPSWLRQDQGWKHĮUDWLRXVHGZLWKWKHLQILQLWH
assumption are very similar, as they both convert in DmNO to DmCO. Here, we compare the 
values used by each assumption and explore their relationship. The Krogh diffusion constant for 
CO versus NO is 1.97 in water. However, studies in our laboratory and others have suggested 
that a value greater than 1.97 should be used when converting DmNO to DmCO (Magini et al., 
2013; Tamhane et al., 2001). For this reason, we are wary of the conclusion by the recent task 
force that a value of 1.97 should be utilized (Zavorsky et al., 2017). Below, we have calculated 
an µHIIHFWLYHĮ¶ for the finite method (see below) which can be used to directly convert DLNO to 
DmCO DVWKHĮ ratio does for the infinite method. The value of this µHIIHFWLYHĮ¶ is shown in 
Figure 4 over a range DLNO/DLCO ratios. 
 ߙ௘௙௙ ൌ  ? כ ൬ ܦܮேைߠேை െ  ?ߠ஼ை כ ൬ ߠேைܦܮேை െ ߠ஼ைܦܮ஼ை൰൰ 
 
This effective Į is less than 1.97 for most DLNO/DLCO ratios using the finite method. The 
lower µeffective Į¶ of the finite method represents the resistance to the transfer of NO through 
the red blood cell that is not taken into account by the infinite method. Some have argued that it 
is inappropriate to vary Į as it is a chemical property based on the solubility of NO and CO. 
However, others have shown that Į should be greater than 1.97 and have suggested that 
confounders such as uptake by the airway epithelium, conversion of NO to N2O, or differences 
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in solubility of NO and CO in biological tissues may have a larger effect on DLNO than red 
blood cell resistance (Tamhane et al., 2001).  Thus, we feel that it is appropriate for the ĮUDWLR to 
vary away from the Krogh coefficient when performing a systematic optimization.   
 
4. DISCUSSION 
The determination of șNO has been chosen based on three studies. First was an in vitro study 
from 1958 determining the second order rate constant of NO with red blood cells(Carlsen and 
Comroe, 1958). Later, the value of 4.5 mlCO/min/mmHg/mlblood was determined from this earlier 
study (Borland and Cox, 1991). A major methodological concern with this method is that the 
concentration of NO used was very high relative to that used for DLNO measurements, possibly 
altering the reaction kinetics and underestimating the rate constant observed in vivo (see CD 
Borland, this issue, +\SRWKHVLV:K\șNO could be finite in vitro but infinite in vivo). Second, a 
2010 study in dogs where oxyglobin was exchanged with red blood cells found an increase in 
DLNO with progressively greater exchange (Borland et al., 2010). These results suggest that șNO 
is finite, but the study was not designed to calculate the actual value. Finally, a 2016 study in 
humans measured DLCO and DLNO while participants breathed 15% and 21% oxygen and 
attempted to estimate șNO; however, this study was not designed to precisely calculate șNO and 
therefore only suggests the continued use of the 4.5 mlCO/min/mmHg/mlblood value (Guenard et 
al., 2016). Based on only these three studies, a recent task force has recommended use of a finite 
șNO for calculation of DmCO and VC (Zavorsky et al., 2017). Furthermore, to the best of our 
knowledge, there have been no studies optimizing șNO to the multiple O2 tension method, a 
method which does not utilize NO, or any other method. Therefore, we suggest that further 
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validation is necessary to determine the correct values for șNO, as well as șCO coefficients, before 
the finite method enters standard practice. 
 
4.1 Theoretical breaking points for each assumption 
In our analysis, both the infinite and finite șNO assumptions yielded extreme outliers in a total of 
four instances (approximately 0.5% of all observations). Though we removed these outliers from 
further analysis, this finding led us to ask under which circumstances each assumption would fail 
to yield reasonable physiologic values for DmCO and VC. Figures 5-6 demonstrates the values 
that would be obtained for DmCO (Figure 5) and VC (Figure 6) over a range of DLNO/DLCO 
values for both methods assuming PO2 of 80 mmHg, 100 mmHg, and 120 mmHg, DLCO of 20 
ml*min-1*mmHg-1 and a DLCO/DLNO ratio of up to 10. 
 
For DmCO, assuming an infinite șNO yields stable DmCO values for any DLNO/DLCO ratio. 
However, assuming a finite șNO causes an asymptote to occur, in this example around 
DLNO/DLCO equals 7, upon which DmCO values increase rapidly to a non-physiologic range.  
This asymptote occurs when DLNO/DLCO is equal to șNO/șCO (note that șCO is dependent on 
PO2). 7KHDV\PSWRWHORFDWLRQLVYHU\VHQVLWLYHWRWKHFKRLFHRIșCO equation in the finite method 
and care must be taken to ensure that the asymptote does not occur in the physiological range of 
DLNO/DLCO ratio. For VC, both the infinite and finite șNO assumptions are stable unless 
DLNO/DLCO approaches Į, where an asymptote occurs yielding rapidly increasing VC values 
which climb to a non-physiologic range. It is important to note that these asymptotes will shift 
depending on the specific values entered into the calculations. 
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All in all, Figures 5-6 demonstrates the mathematical constraints that are incorporated into the 
determination of DmCO and VC from values of DLCO and DLNO, regardless of the assumptions 
made as to the correct value of șNO. While DmCO and VC are themselves physiologic variables, 
the calculations that have been established to determine these variables incorporate an 
unavoidable complication. The DLNO/DLCO values at which each assumption yields an 
asymptote is potentially concerning in two cases. First, DmCO values calculated using a finite șNO 
under normal conditions are unlikely to encroach upon the asymptote, as a physiologic 
DLNO/DLCO value is generally around 4-5 (Hughes and van der Lee, 2013). However, in 
instances such as altitude, where PO2 is lower and the asymptote is therefore shifted to lower 
DLNO/DLCO ratios, the DLNO/DLCO ratio may fall within the range where DmCO rapidly 
increases to large, non-physiologic values. Second, VC values calculated using the infinite șNO 
assumption and the single breath method, where the optimal Į value has been optimized at ~ 4.4, 
also causes the asymptote to occur at a physiologic range for DLNO/DLCO. However, as can be 
seen in Table 2, the single breath method tends to yield higher DLNO/DLCO ratios than that of 
the rebreathe method (presently, mean 5.39 ± 0.43 for single breath vs. 3.58 ± 0.59 for 
rebreathe), such that approaching the asymptote is not usually an issue. The observation that 
DLNO/DLCO is slightly higher using the single breath method is found in our laboratory and 
others (Ceridon et al., 2010; Ceridon et al., 2011; Coffman et al., 2016; Zavorsky and Lands, 
2005; Zavorsky and Murias, 2006). 
 
4.2 Key Points 
7REHFOHDUZHDJUHHWKDWșNO is, in a strict biochemical sense, not infinite, as no biological 
process can occur instantaneously. Indeed, as we have highlighted above, there is experimental 
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data which demonstrates a resistance to combination of NO with hemoglobin that resides in the 
red cell (Azarov et al., 2011; Sakai et al., 2008),QWKLVVHQVHZHFRQFHGHWKDWDILQLWHșNO may 
be a more accurate representation of gas transfer from the environment to hemoglobin in blood. 
However, in the case of calculating DmCO and VCWKHYDOXHRIșNO has not been optimized 
relative to the gold standard multiple O2 method or in any other way. Therefore, the assumption 
RIDQLQILQLWHșNO UHODWLYHWRșCO is still appropriate. While our laboratory recognizes that 
FRQVLGHULQJșNO infinite may not be ideal, we argue two main points that cause our group to be 
ZDU\RIWKHXVHRIDILQLWHșNO, in its current form, at this point. 
 
)LUVWZKHQZHKDYHDSSOLHGWKHILQLWHșNO value to our calculations of DmCO and VC using the 
single breath technique, we obtain values which do not increase as expected during exercise. 
This is concerning, as much of the research performed in our laboratory relies on accurate 
measures of the change in DmCO and VC during submaximal and maximal exercise bouts. 
Second, as is the case in any scientific field, new methodology must be validated against a gold-
standard. While some groups may argue that there is no gold standard in the case of DmCO and 
VCZHIHHOLWLVLPSRUWDQWWKDWWKHILQLWHșNO calculations be validated against a method that does 
not utilize NO. We have performed such optimizations on our calculations, which assume an 
LQILQLWHșNO, using both the single breath and rebreathe techniques (Ceridon et al., 2010; Coffman 
et al., 2016). :HIHHOLWLVLPSRUWDQWWKDWWKRVHJURXSVWKDWDUHLQYHVWHGLQWKHXVHRIDILQLWHșNO 
apply a similar method, where the șNO value would be systematically varied with respect to the 
other two required assumptions WKHșCO equation and Krogh coefficient) RIWKHILQLWHșNO 
calculations. This methodology would produce optimized values for all three calculation 
parameter assumptions, thus adding confidence to the use of the finite method. 
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All in all, while the finite șNO calculations have merit and may move into standard practice in the 
future, we feel that two main LVVXHVUHPDLQZLWKWKHXVHRIDILQLWHșNO in practice, including the 
lack of validation of the currently established șNO value as well as the non-physiological 
response to exercise.  
 
Additionally, we cannot stress enough that while alveolar-capillary membrane conductance and 
pulmonary-capillary blood volume are anatomical phenomena, the calculations that have been 
established to determine these variables from measured values of DLNO and DLCO are entirely 
dependent on the mathematical relationships underlying the given assumptions. In this sense, 
perhaps it is better to consider DmCO and VC functional variables that can be used to observe 
changes over time, whether that be during exercise studies or clinically in disease, instead of true 
representations of anatomy.  
 
4.3 Conclusions 
The nuances of the calculations required for both assumptions can be discussed endlessly, but 
our ability to utilize DmCO and VC to contribute meaningfully to the field is the overriding goal. 
We have shown that the values themselves are very dependent on the mathematical relationships, 
and therefore are likely not entirely in agreement with the physiology regardless of the 
assumptions. However, by using a consistent method for calculation of DmCO and VC, it is 
entirely possible to observe changes within study participants or differences between study 
groups. If DmCO and VC are to eventually enter clinical practice, an assumption regarding șNO 
must be determined, in addition to a șCO equation and ĮUDWLR, and standardized across the 
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practice. Once the optimal calculation parameters have been chosen, it will then be possible to 
systematically investigate appropriate cutoffs for the determination of disease states. At the 
current time, with a number of conflicting assumptions and methods, the results are simply too 
variable to determine how a particular result should be interpreted. In the research arena, the 
choice of calculation parameters is of little concern as long as the resulting data remain within 
the physiologic range (i.e. positive) and have appropriate response to stimuli, such as pulmonary-
capillary blood volume increasing with exercise. While we respect the work of the recent ERS 
task force, we believe their findings are premature as no study has been designed to calculate an 
exact șNO in vivo in humans, and we are also uncomfortable with their conclusions regarding the 
correct DmNO/DmCO Į-) ratio. Additionally, the ERS task force has not presented any new 
evidence for use of a finite șNO beyond the evidence discussed above (Zavorsky et al., 2017). 
Therefore at this time, we suggest the continued use of the assumption that șNO is infinite until 
further optimization of the finite șNO method can be performed. 
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Figure 1: DmCO and VC values calculated from rebreathe data using both the finite and 
LQILQLWHșNO assumptions. Both assumptions yield reasonable values for DmCO and VC ± i.e., 
positive and within range of previously reported values. Outliers (red +) are defined as ± 2.7 
standard deviations from the mean. Finite DmCO values are significantly greater that infinite 
DmCO values (p < 0.001); VC values are not statistically different. DmCO, alveolar capillary 
membrane conductance; VC, pulmonary capillary blood volume. 
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Figure 2: DmCO and VC values calculated from single breath data using both the finite and 
LQILQLWHșNO assumptions. Both assumptions yield reasonable values for DmCO and VC ± i.e., 
positive and within range of previously reported values. Outliers (red +) are defined as ± 2.7 
standard deviations from the mean. Finite DmCO values are significantly greater, and finite VC 
values are significantly lower, that the infinite assumption values (both p < 0.001). DmCO, 
alveolar capillary membrane conductance; VC, pulmonary capillary blood volume. 
 
Figure 3: Response of DmCO and VC to incremental exercise calculated from rebreathe 
data. A linear mixed effects model was implemented to separate the individual and group effects 
on either DmCO or VC throughout incremental cycling exercise. The group effects for both the 
infinite and finite șNO assumptions are plotted as a function of workload. For both assumptions, 
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DmCO and VC increased significantly throughout exercise (all p < 0.001). DmCO, alveolar 
capillary membrane conductance; VC, pulmonary capillary blood volume. 
 
 
 
)LJXUH(IIHFWLYHĮUDWLRIRUWKHFRQYHUVLRQRI'/12WR'PCO IRUWKHILQLWHșNO 
assumption. 7KHHIIHFWLYHĮUDWLR, which converts DLNO directly to DmCO IRUWKHILQLWHșNO 
assumption, was calculated for a range for DLNO/DLCO ratios. The resulting effective Į ratio is 
lower than the Krogh Coefficient (1.97) because the finite șNO assumption calculations only 
factor in the theoretical red blood cell resistance to the transfer of NO. The resulting effective Į 
ratio is also lower than the Į ratio used under the infinite șNO assumption (2.26) for 
DLNO/DLCO ratios below ~6.5.  
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Figure 5: Theoretical DmCO values over a range of DLNO/DLCO ratios. DmCO was 
calculated under both the infinite and finite șNO assumptions using DLCO = 20 ml/min/mmHg. 
The finite calculation of DmCO is also dependent on PO2; values of 80, 100, and 120 mmHg are 
show here. While the infinite calculation of DmCO is stable over a large range of DLNO/DLCO 
ratios, the finite calculation of DmCO rapidly increases as the DLNO/DLCO ratio increases. 
DLCO, lung diffusing capacity for carbon monoxide; DLNO, lung diffusing capacity for nitric 
oxide; DmCO, alveolar capillary membrane conductance. 
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Figure 6: Theoretical VC values over a range of DLNO/DLCO ratios. VC was calculated 
under both the infinite and finite șNO assumptions using DLCO = 20 ml/min/mmHg. The infinite 
calculation of VC is dependent on the technique used in our laboratory; hence, both rebreathe and 
single breath are shown here. Under both assumptions, calculation of VC is increases rapidly 
ZKHQWKH'/12'/&2UDWLRLVHTXDOWRWKHĮUDWLR.URJKFRHIILFLHQWXVHG'/&2OXQJ
diffusing capacity for carbon monoxide; DLNO, lung diffusing capacity for nitric oxide; VC, 
pulmonary capillary blood volume. 
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Table 1. Source of over 750 DLCO and DLNO observations 
 
 
 
 
 
 
 
 
Values are reported as mean ± SD. BMI, body mass index; HF, heart failure; Wpeak, peak work rate. 
  
Study ID Age (y) Height (cm) Weight (kg) BMI (kg/m2) Exercise Condition 
  
 Rebreathe 
1.  66.5 ± 10.0 172.4 ± 10.3 82.2 ± 17.6 27.8 ± 4.4 -- HF + Control 
2.  59.7 ± 10.6 174.5 ± 8.9 85.8 ± 17.6 28.1 ± 5.0 -- HF + Control 
3. 25.9 ± 4.0 176.4 ± 11.7 71.3 ± 10.5 22.8 ± 2.1 Incremental to 70% Wpeak Healthy 
4.  46.1 ± 20.6 176.2 ± 5.1 75.1 ± 7.4 24.2 ± 2.4 Incremental to 90% Wpeak Healthy 
Average 49.6 ± 19.6 175.3 ± 8.2 78.7 ± 14.1 25.6 ± 4.1 -- -- 
  
 Single Breath 
5.  25.1 ± 2.4 180.7 ± 6.4 74.0 ± 10.1 22.6 ± 2.4 Constant @ 80 Watts Healthy 
6.  26.9 ± 3.3 173.5 ± 7.4 65.4 ± 6.8 21.7 ± 1.5 Constant @ 82 ± 27 Watts Healthy 
Average 25.9 ± 2.9 177.7 ± 7.7 70.6 ± 9.9 22.3 ± 2.1 -- -- 
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Table 2. DLCO/DLNO data and resulting DmCO and VC values calculated via both the infinite and finite șNO assumptions 
 Infinite Method Finite Method P-value 
 
  
 Rebreathe  
DLCO 26.5 ± 11.9  
Range 5.9 ± 72.1  
DLNO 93.1 ± 40.0  
Range 15.1 ± 276.9  
DLNO/DLCO 3.58 ± 0.59  
Range 2.33 ± 7.03  
 
       
DmCO 41.2 ± 17.7 63.8 ± 31.1 < 0.001 
Range 6.7 ± 122.5 8.33 ± 319.8  
VC 85.8 ± 46.3 89.8 ± 43.3 0.111 
Range 18.1 ± 497.2 20.1 ± 253.3  
 
  
 Single Breath  
DLCO 40.7 ± 8.2  
Range 29.3 ± 68.6  
DLNO 217.7 ± 36.8  
Range 165.4 ± 335.4  
DLNO/DLCO 5.39 ± 0.43  
Range 4.59 ± 6.62  
 
       
DmCO 49.5 ± 8.4 281.7 ± 81.5 < 0.001 
Range 37.6 ± 76.2 183.6 ± 55.8  
VC 223.2 ± 141.2 82.5 ± 18.7 < 0.001 
Range 73.0 ± 878.5 55.8 ± 144.4  
Values are reported as mean ± SD. Values include all rest, submaximal, and incremental exercise observations as well as data from both healthy individuals and 
heart failure patients. DLCO, lung diffusing capacity for carbon monoxide; DLNO, lung diffusing capacity for nitric oxide; DmCO, alveolar capillary membrane 
conductance; VC, pulmonary capillary blood volume. 
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Table 3. Rest and submaximal exercise values for DmCO and VC using the single breath technique calculated via both the infinite and finite șNO assumptions 
 Rest Exercise (80 ± 17 W) Absolute Change % Change P-value 
 
   
 
Infinite Method 
DmCO 45.6 ± 6.5 53.7 ± 8.2 7.7 ± 3.6 16.9 ± 7.3 < 0.001 
Range 37.6 ± 63.7 42.0 ± 76.2 1.4 ± 18.8 2.9 ± 31.4  
VC 162.6 ± 68.6 288.9 ± 168.9 129.0 ± 160.7 92.0 ± 112.2 < 0.001 
Range 73.0 ± 427.8 109.7 ± 878.5 ±119.5 ± 725.1 ±52.1 ± 472.4  
 
   
 
Finite Method 
DmCO 279.1 ± 95.4 284.5 ± 64.2 0.1 ± 76.9 4.79 ± 27.0 0.498 
Range 185.4 ± 608.0 183.6 ± 422.7 ±219.3 ± 177.0 ±37.9 ± 95.5  
VC 72.7 ± 12.9 93.1 ± 18.3 20.3 ± 10.9 28.5 ± 16.4 < 0.001 
Range 55.8 ± 110.9 64.5 ± 144.4 ±3.6 ± 39.9 ±4.9 ± 69.8  
Values are reported as mean ± SD. DmCO, alveolar capillary membrane conductance; VC, pulmonary capillary blood volume. 
 
